Liam Conejo Ramos, whose detention with his father sparked national outcry, is back in Minnesota following a federal judge's order for their release from a Texas facility.
The search for Isabella Comas, last seen in Avondale on January 11, continues after her abandoned car was discovered with blood stains. Her boyfriend, Thomas Rodriguez, a convicted felon, is in custody on unrelated charges as authorities plead for public assistance.
A Florida woman who authorities say was in a delusional state, fearing imminent bomb attacks on U.S. cities, was located with her two young children following a multi-state search. The family was found unharmed after an alert was issued.
A San Antonio family's morning commute turned to terror when a driver, angered by a brief honk, opened fire on their vehicle, critically wounding a child in the backseat.
A 51-year-old Airbnb host in Kissimmee has been arrested after multiple residents reported lewd behavior, including an incident involving a vacuum cleaner, at the Windsor Hills Resort community near Walt Disney World.
In an exclusive 'Face the Nation' interview, Nobel laureate María Corina Machado discusses Venezuela's future after U.S. intervention, while domestic debates over ICE tactics and a partial government shutdown highlight deepening political divisions.
NextEra Energy is aggressively pursuing long-term power supply agreements with major technology firms, positioning itself as a one-stop shop for clean, reliable electricity to fuel the data center boom. Its strategy hinges on a three-pronged approach: record renewable energy additions, potential nuclear fleet expansion, and a pioneering gas plant with carbon capture technology developed with ExxonMobil.
Texas Instruments (TXN) reported a 70% year-over-year surge in data center orders, prompting the company to break out the segment separately. Management forecasts the first sequential revenue growth since 2008, citing improving industrial trends and AI-related infrastructure spending.
While Insas Berhad's (KLSE:INSAS) share price has underperformed the broader market over three years, its total shareholder return tells a different story. A closer look reveals a disconnect between stock performance and underlying business fundamentals, prompting investor scrutiny.
Argentina has reportedly purchased $808 million in Special Drawing Rights from the U.S. Treasury to cover an upcoming interest payment to the International Monetary Fund, highlighting the nation's ongoing financial pressures.
Oracle Corp. plans a colossal $45-$50 billion capital raise in 2026 to expand its cloud infrastructure, aiming to meet surging demand from AI giants like OpenAI and Nvidia. The move comes as the company's aggressive data center spending pushes its free cash flow negative, a condition projected to last for years.
Micron Technology, a key player in memory chips, is poised for explosive earnings growth fueled by insatiable AI demand. Yet, its cyclical nature and commoditized market pose significant long-term risks for investors.
As artificial intelligence drives an unprecedented surge in electricity demand, one utility company—Constellation Energy—is uniquely positioned with its vast nuclear fleet to meet the need, turning an industry-wide bottleneck into a significant growth opportunity.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
Goldcom's (GOLD) shares have soared nearly 90% in the past year, leaving investors to grapple with a critical question: has the market already priced in all the good news, or is there still room to run? A deep dive into the valuation metrics reveals a stark contradiction.
Marketing automation firm Klaviyo is deepening its AI capabilities with a new ChatGPT app and a Wunderkind partnership. Yet, despite these strategic moves, its stock performance tells a more cautious story, leaving investors to weigh its growth potential against a significant valuation discount.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
Bayer's share price has more than doubled in the past 12 months, yet key valuation models suggest a significant gap remains between its market price and intrinsic value. We examine the metrics behind the rally and the lingering legal and portfolio challenges facing the company.
DoorDash is deploying autonomous delivery robots in the suburbs while advocating for legislation to improve food access for rural seniors, signaling a strategic push beyond its urban core into new markets and use cases.
